SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Samantha Giordano, Victor Darley-Usmar, Jianhua Zhang, Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease, Redox Biology, 2014, 2, 82

    CrossRef

  2. 2
    Jennifer McLachlan, Elisabeth Beattie, Michael P. Murphy, Caline H.H. Koh-Tan, Erin Olson, Wendy Beattie, Anna F. Dominiczak, Stuart A. Nicklin, Delyth Graham, Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function, Journal of Hypertension, 2014, 32, 3, 555

    CrossRef

  3. 3
    Sia Lee Yoong, Bin Sheng Wong, Qi Ling Zhou, Chee Fei Chin, Jian Li, Thirumalai Venkatesan, Han Kiat Ho, Victor Yu, Wee Han Ang, Giorgia Pastorin, Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin, Biomaterials, 2014, 35, 2, 748

    CrossRef

  4. 4
    Witold Korytowski, Katarzyna Wawak, Pawel Pabisz, Jared C. Schmitt, Albert W. Girotti, Macrophage mitochondrial damage from StAR transport of 7-hydroperoxycholesterol: Implications for oxidative stress-impaired reverse cholesterol transport, FEBS Letters, 2014, 588, 1, 65

    CrossRef

  5. 5
    Meagan J. McManus, Michael P. Murphy, James L. Franklin, Mitochondria-derived reactive oxygen species mediate caspase-dependent and -independent neuronal deaths, Molecular and Cellular Neuroscience, 2014,

    CrossRef

  6. 6
    Carolyn P. Ojano-Dirain, Patrick J. Antonelli, Colleen G. Le Prell, Mitochondria-Targeted Antioxidant MitoQ Reduces Gentamicin-Induced Ototoxicity, Otology & Neurotology, 2014, 35, 3, 533

    CrossRef

  7. 7
    Huajun Jin, Arthi Kanthasamy, Anamitra Ghosh, Vellareddy Anantharam, Balaraman Kalyanaraman, Anumantha G. Kanthasamy, Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 8, 1282

    CrossRef

  8. 8
    Jia Liu, Lu-ning Wang, Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone, CNS Drugs, 2014, 28, 1, 63

    CrossRef

  9. 9
    Dao-Fu Dai, Ying Chiao, David J Marcinek, Hazel H Szeto, Peter S Rabinovitch, Mitochondrial oxidative stress in aging and healthspan, Longevity & Healthspan, 2014, 3, 1, 6

    CrossRef

  10. 10
    Marianna Sikorska, Patricia Lanthier, Harvey Miller, Melissa Beyers, Caroline Sodja, Bogdan Zurakowski, Sandhya Gangaraju, Siyaram Pandey, Jagdeep K. Sandhu, Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease, Neurobiology of Aging, 2014, 35, 10, 2329

    CrossRef

  11. 11
    Amaal AlDakheel, Lorraine V. Kalia, Anthony E. Lang, Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease, Neurotherapeutics, 2014, 11, 1, 6

    CrossRef

  12. 12
    N. Cardenes, C. Corey, L. Geary, S. Jain, S. Zharikov, S. Barge, E. M. Novelli, S. Shiva, Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation, Blood, 2014, 123, 18, 2864

    CrossRef

  13. 13
    Rachel K Dongworth, Andrew R Hall, Niall Burke, Derek J Hausenloy, Targeting mitochondria for cardioprotection: examining the benefit for patients, Future Cardiology, 2014, 10, 2, 255

    CrossRef

  14. 14
    Angelique Camilleri, Neville Vassallo, The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease, CNS Neuroscience & Therapeutics, 2014, 20, 7
  15. 15
    R. Anand, Kiran Dip Gill, Abbas Ali Mahdi, Therapeutics of Alzheimer's disease: Past, present and future, Neuropharmacology, 2014, 76, 27

    CrossRef

  16. 16
    Alexander N. Lukashev, Maxim V. Skulachev, Victoria Ostapenko, Alla Yu. Savchenko, V.V. Pavshintsev, Vladimir P. Skulachev, The Mitochondrion in Aging and Disease, 2014,

    CrossRef

  17. 17
    Tian-yao Shi, Da-qing Zhao, Hai-bo Wang, Shufang Feng, Shui-bing Liu, Jiang-hao Xing, Yang Qu, Peng Gao, Xiao-li Sun, Ming-gao Zhao, A New Chiral Pyrrolyl α-Nitronyl Nitroxide Radical Attenuates β-Amyloid Deposition and Rescues Memory Deficits in a Mouse Model of Alzheimer Disease, Neurotherapeutics, 2013, 10, 2, 340

    CrossRef

  18. 18
    Melissa Millard, John D. Gallagher, Bogdan Z. Olenyuk, Nouri Neamati, A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers, Journal of Medicinal Chemistry, 2013, 56, 22, 9170

    CrossRef

  19. You have free access to this content19
    Michael H Parkinson, Jörg B. Schulz, Paola Giunti, Co-enzyme Q10 and idebenone use in Friedreich's ataxia, Journal of Neurochemistry, 2013, 126,
  20. 20
    Thomas Müller, Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson’s disease, Expert Review of Neurotherapeutics, 2013, 13, 6, 707

    CrossRef

  21. 21
    Estelle Hirzel, Peter W. Lindinger, Swarna Maseneni, Maria Giese, Véronique Virginie Rhein, Anne Eckert, Matthias Hoch, Stephan Krähenbühl, Alex N. Eberle, Differential modulation of ROS signals and other mitochondrial parameters by the antioxidants MitoQ, resveratrol and curcumin in human adipocytes, Journal of Receptors and Signal Transduction, 2013, 33, 5, 304

    CrossRef

  22. 22
    Orest Hurko, Drug Development for Rare Mitochondrial Disorders, Neurotherapeutics, 2013, 10, 2, 286

    CrossRef

  23. 23
    Sagar Kansara, Akash Trivedi, Sheng Chen, Joseph Jankovic, Weidong Le, Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?, Journal of Neural Transmission, 2013, 120, 1, 197

    CrossRef

  24. 24
    Ilse S. Pienaar, Patrick F. Chinnery, Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression, Pharmacology & Therapeutics, 2013, 137, 1, 1

    CrossRef

  25. 25
    M.W. Anders, Exploiting endobiotic metabolic pathways to target xenobiotic antioxidants to mitochondria, Mitochondrion, 2013, 13, 5, 454

    CrossRef

  26. 26
    Adam L. Orr, Deepthi Ashok, Melissa R. Sarantos, Tong Shi, Robert E. Hughes, Martin D. Brand, Inhibitors of ROS production by the ubiquinone-binding site of mitochondrial complex I identified by chemical screening, Free Radical Biology and Medicine, 2013, 65, 1047

    CrossRef

  27. 27
    Marina Bayeva, Mihai Gheorghiade, Hossein Ardehali, Mitochondria as a Therapeutic Target in Heart Failure, Journal of the American College of Cardiology, 2013, 61, 6, 599

    CrossRef

  28. 28
    Amarjargal Dashdorj, Jyothi KR, Sangbin Lim, Ara Jo, Minh Nguyen, Joohun Ha, Kyung-Sik Yoon, Hyo Kim, Jae-Hoon Park, Michael P Murphy, Sung Kim, Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines, BMC Medicine, 2013, 11, 1, 178

    CrossRef

  29. 29
    Jan Gruber, Sheng Fong, Ce-Belle Chen, Sialee Yoong, Giorgia Pastorin, Sebastian Schaffer, Irwin Cheah, Barry Halliwell, Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing, Biotechnology Advances, 2013, 31, 5, 563

    CrossRef

  30. 30
    Gang Cheng, Jacek Zielonka, Donna M McAllister, A Mackinnon, Joy Joseph, Michael B Dwinell, Balaraman Kalyanaraman, Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death, BMC Cancer, 2013, 13, 1, 285

    CrossRef

  31. 31
    Peter G. Finichiu, Andrew M. James, Lesley Larsen, Robin A. J. Smith, Michael P. Murphy, Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pK a: implications for the design of mitochondrial probes and therapies, Journal of Bioenergetics and Biomembranes, 2013, 45, 1-2, 165

    CrossRef

  32. 32
    Rajnish K. Chaturvedi, M. Flint Beal, Mitochondrial Diseases of the Brain, Free Radical Biology and Medicine, 2013, 63, 1

    CrossRef

  33. 33
    Carolyn M. Porteous, David K. Menon, Franklin I. Aigbirhio, Robin A.J. Smith, Michael P. Murphy, P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain, Biochimica et Biophysica Acta (BBA) - General Subjects, 2013, 1830, 6, 3458

    CrossRef

  34. 34
    L. Li, L. Brichard, L. Larsen, D. K. Menon, R. A. J. Smith, M. P. Murphy, F. I. Aigbirhio, Radiosynthesis of 11-[18F]fluoroundecyltriphenylphosphonium (MitoF) as a potential mitochondria-specific positron emission tomography radiotracer, Journal of Labelled Compounds and Radiopharmaceuticals, 2013, 56, 14
  35. 35
    James M. Flynn, Simon Melov, SOD2 in mitochondrial dysfunction and neurodegeneration, Free Radical Biology and Medicine, 2013, 62, 4

    CrossRef

  36. 36
    M. Scott Vandiver, Bindu D. Paul, Risheng Xu, Senthilkumar Karuppagounder, Feng Rao, Adele M. Snowman, Han Seok Ko, Yun Il Lee, Valina L. Dawson, Ted M. Dawson, Nilkantha Sen, Solomon H. Snyder, Sulfhydration mediates neuroprotective actions of parkin, Nature Communications, 2013, 4, 1626

    CrossRef

  37. 37
    Micheal S Ward, Amelia K Fotheringham, Mark E Cooper, Josephine M Forbes, Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease, Current Opinion in Pharmacology, 2013, 13, 4, 654

    CrossRef

  38. 38
    María E. Solesio, Tracy A. Prime, Angela Logan, Michael P. Murphy, María del Mar Arroyo-Jimenez, Joaquín Jordán, María F. Galindo, The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 1, 174

    CrossRef

  39. 39
    M. Lagouge, N.-G. Larsson, The role of mitochondrial DNA mutations and free radicals in disease and ageing, Journal of Internal Medicine, 2013, 273, 6
  40. 40
    Anthony E. Lang, Eldad Melamed, Werner Poewe, Olivier Rascol, Trial designs used to study neuroprotective therapy in Parkinson's disease, Movement Disorders, 2013, 28, 1
  41. 41
    Geoffrey F. Kelso, Andrej Maroz, Helena M. Cochemé, Angela Logan, Tracy A. Prime, Alexander V. Peskin, Christine C. Winterbourn, Andrew M. James, Meredith F. Ross, Sally Brooker, Carolyn M. Porteous, Robert F. Anderson, Michael P. Murphy, Robin A.J. Smith, A Mitochondria-Targeted Macrocyclic Mn(II) Superoxide Dismutase Mimetic, Chemistry & Biology, 2012, 19, 10, 1237

    CrossRef

  42. 42
    Brian P. Dranka, Jacek Zielonka, Anumantha G. Kanthasamy, Balaraman Kalyanaraman, Alterations in bioenergetic function induced by Parkinson’s disease mimetic compounds: lack of correlation with superoxide generation, Journal of Neurochemistry, 2012, 122, 5
  43. 43
    Dao-Fu Dai, Tony Chen, Simon C. Johnson, Hazel Szeto, Peter S. Rabinovitch, Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease, Antioxidants & Redox Signaling, 2012, 16, 12, 1492

    CrossRef

  44. 44
    Tanecia Mitchell, Victor Darley-Usmar, Metabolic syndrome and mitochondrial dysfunction: insights from preclinical studies with a mitochondrially targeted antioxidant, Free Radical Biology and Medicine, 2012, 52, 5, 838

    CrossRef

  45. 45
    Robin A.J. Smith, Richard C. Hartley, Helena M. Cochemé, Michael P. Murphy, Mitochondrial pharmacology, Trends in Pharmacological Sciences, 2012, 33, 6, 341

    CrossRef

  46. 46
    Partha Mukhopadhyay, Bėla Horváth, Zsuzsanna Zsengellėr, Sándor Bátkai, Zongxian Cao, Malek Kechrid, Eileen Holovac, Katalin Erdėlyi, Galin Tanchian, Lucas Liaudet, Isaac E. Stillman, Joy Joseph, Balaraman Kalyanaraman, Pál Pacher, Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia–reperfusion: Therapeutic potential of mitochondrially targeted antioxidants, Free Radical Biology and Medicine, 2012, 53, 5, 1123

    CrossRef

  47. 47
    Martin Pelletier, Talya S. Lepow, Leah K. Billingham, Michael P. Murphy, Richard M. Siegel, New tricks from an old dog: Mitochondrial redox signaling in cellular inflammation, Seminars in Immunology, 2012, 24, 6, 384

    CrossRef

  48. 48
    DAVID M SMALL, JEFF S COOMBES, NIGEL BENNETT, DAVID W JOHNSON, GLENDA C GOBE, Oxidative stress, anti-oxidant therapies and chronic kidney disease, Nephrology, 2012, 17, 4
  49. 49
    M. W. C. Rousseaux, P. C. Marcogliese, D. Qu, S. J. Hewitt, S. Seang, R. H. Kim, R. S. Slack, M. G. Schlossmacher, D. C. Lagace, T. W. Mak, D. S. Park, Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease, Proceedings of the National Academy of Sciences, 2012, 109, 39, 15918

    CrossRef

  50. 50
    Hans Lassmann, Jack van Horssen, Don Mahad, Progressive multiple sclerosis: pathology and pathogenesis, Nature Reviews Neurology, 2012, 8, 11, 647

    CrossRef

  51. 51
    Marlene Jimenez-Del-Rio, Carlos Velez-Pardo, The Bad, the Good, and the Ugly about Oxidative Stress, Oxidative Medicine and Cellular Longevity, 2012, 2012, 1

    CrossRef

  52. 52
    Aracely Garcia-Garcia, Laura Zavala-Flores, Humberto Rodriguez-Rocha, Rodrigo Franco, Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's Disease, Antioxidants & Redox Signaling, 2012, 17, 12, 1764

    CrossRef

  53. 53
    Robin Smith, Richard Hartley, Michael Murphy, Mitochondrial Signaling in Health and Disease, 2012,

    CrossRef

  54. 54
    Jerry R. Colca, Douglas L. Feinstein, Current State of Alzheimer's Disease Research and Therapeutics, 2012,

    CrossRef

  55. 55
    Christian Cortés-Rojo, Mirella Estrada-Villagómez, Elizabeth Calderón-Cortés, Mónica Clemente-Guerrero, Ricardo Mejía-Zepeda, Istvan Boldogh, Alfredo Saavedra-Molina, Electron transport chain dysfunction by H2O2 is linked to increased reactive oxygen species production and iron mobilization by lipoperoxidation: studies using Saccharomyces cerevisiae mitochondria, Journal of Bioenergetics and Biomembranes, 2011, 43, 2, 135

    CrossRef

  56. 56
    Robin A.J. Smith, Richard C. Hartley, Michael P. Murphy, Mitochondria-Targeted Small Molecule Therapeutics and Probes, Antioxidants & Redox Signaling, 2011, 15, 12, 3021

    CrossRef

  57. 57
    Balu K. Chacko, Anup Srivastava, Michelle S. Johnson, Gloria A. Benavides, Mi Jung Chang, Yaozu Ye, Nirag Jhala, Michael P. Murphy, Balaraman Kalyanaraman, Victor M. Darley-Usmar, Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis, Hepatology, 2011, 54, 1
  58. 58
    Ross B. Mounsey, Peter Teismann, Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  59. 59
    Lan-Feng Dong, Victoria J.A. Jameson, David Tilly, Lubomir Prochazka, Jakub Rohlena, Karel Valis, Jaroslav Truksa, Renata Zobalova, Elahe Mahdavian, Katarina Kluckova, Marina Stantic, Jan Stursa, Ruth Freeman, Paul K. Witting, Erik Norberg, Jacob Goodwin, Brian A. Salvatore, Jana Novotna, Jaroslav Turanek, Miroslav Ledvina, Pavel Hozak, Boris Zhivotovsky, Mark J. Coster, Stephen J. Ralph, Robin A.J. Smith, Jiri Neuzil, Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy, Free Radical Biology and Medicine, 2011, 50, 11, 1546

    CrossRef

  60. 60
    Jakub Rohlena, Lan-Feng Dong, Katarina Kluckova, Renata Zobalova, Jacob Goodwin, David Tilly, Jan Stursa, Alena Pecinova, Anatoly Philimonenko, Pavel Hozak, Jaideep Banerjee, Miroslav Ledvina, Chandan K. Sen, Josef Houstek, Mark J. Coster, Jiri Neuzil, Mitochondrially Targeted α-Tocopheryl Succinate Is Antiangiogenic: Potential Benefit Against Tumor Angiogenesis but Caution Against Wound Healing, Antioxidants & Redox Signaling, 2011, 15, 12, 2923

    CrossRef

  61. 61
    Magali Dumont, M. Flint Beal, Neuroprotective strategies involving ROS in Alzheimer disease, Free Radical Biology and Medicine, 2011, 51, 5, 1014

    CrossRef

  62. 62
    Josef Finsterer, Parkinson's syndrome and Parkinson's disease in mitochondrial disorders, Movement Disorders, 2011, 26, 5
  63. 63
    Yuxing Zhang, Yanzhi Du, Weidong Le, Kankan Wang, Nelly Kieffer, Ji Zhang, Redox Control of the Survival of Healthy and Diseased Cells, Antioxidants & Redox Signaling, 2011, 15, 11, 2867

    CrossRef

  64. You have full text access to this Open Access content64
    Susanne M. Pritchard, Philip J. Dolan, Alisa Vitkus, Gail V.W. Johnson, The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics, Journal of Cellular and Molecular Medicine, 2011, 15, 8
  65. 65
    Anu Suomalainen, Therapy for mitochondrial disorders: Little proof, high research activity, some promise, Seminars in Fetal and Neonatal Medicine, 2011, 16, 4, 236

    CrossRef

  66. 66
    A. Y. Estevez, J. S. Erlichman, Oxidative Stress: Diagnostics, Prevention, and Therapy, 2011,

    CrossRef

  67. 67
    Robin A.J. Smith, Michael P. Murphy, Animal and human studies with the mitochondria-targeted antioxidant MitoQ, Annals of the New York Academy of Sciences, 2010, 1201, 1
  68. 68
    Hyoung Jin Kim, Sun Young Koo, Bong-Hyun Ahn, Oeuk Park, Doo Hoe Park, Dong Ook Seo, Jong Heon Won, Hyeon Joo Yim, Hyo-Shin Kwak, Heui Sul Park, Chul Woong Chung, Young Leem Oh, Soon Ha Kim, NecroX as a novel class of mitochondrial reactive oxygen species and ONOO− scavenger, Archives of Pharmacal Research, 2010, 33, 11, 1813

    CrossRef

  69. 69
    Balu K. Chacko, Colin Reily, Anup Srivastava, Michelle S. Johnson, Yaozu Ye, Elena Ulasova, Anupam Agarwal, Kurt R. Zinn, Michael P. Murphy, Balaraman Kalyanaraman, Victor Darley-Usmar, Prevention of diabetic nephropathy in Ins2+/−AkitaJmice by the mitochondria-targeted therapy MitoQ, Biochemical Journal, 2010, 432, 1, 9

    CrossRef